Roupen Odabashian: What founders get wrong about AI agents in healthcare
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host at OncoDaily, posted on LinkedIn:
“What founders get wrong about AI agents in healthcare!
The buzz around AI agents is everywhere, yet many physicians are still figuring out what ChatGPT can do.
It feels like there’s a disconnect between the rapid tech push and the realities on the ground in healthcare.
The aggressive pricing I’m seeing from some healthtech startups when pitching hospitals is honestly jaw-dropping.
We’re talking about solutions with exorbitant price tags for things that conceptually might not cost much at all. This “rip-the-bandage-off” approach of flooding healthcare with expensive tech all at once isn’t working.
Healthcare, in many ways, is like someone stepping out of a 40-year time capsule when it comes to technology.
Adoption needs to be a gradual process.
If we genuinely want to see these innovations used, we need affordable pricing models – think high volume, lower margin initially – to prove value and build trust.
Focus on sustainable integration, not just aggressive sales tactics.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023